Emtricitabine Completed Phase 2 / 3 Trials for Human Immunodeficiency Virus (HIV) Infections Prevention

IndicationsStatusPurposePhase
CompletedPrevention2 / 3
clinicaltrials.gov IdentifierTitleDrugs
NCT01769456An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
NCT01772823An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
NCT01505114Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women
NCT01033942Pre-Exposure Prophylaxis in YMSM
NCT01327651The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP)
NCT00705679Safety and Effectiveness of TFV 1% Gel, TDF Tablets, and FTC/TDF Tablets in Preventing HIV in Women